Tandem Diabetes Care, Inc. (TNDM)

Market Cap	1.32B
Revenue (ttm)	771.42M
Net Income (ttm)	-208.46M
Shares Out	65.21M
EPS (ttm)	-3.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,455,206
Open	20.01
Previous Close	19.82
Day's Range	19.90 - 20.89
52-Week Range	13.82 - 47.18
Beta	0.94
Analysts	Buy
Price Target	36.36 (+79.64%)
Earnings Date	Nov 1, 2023

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update the...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 14, 2013
• Employees: 2,600
• Stock Exchange: NASDAQ
• Ticker Symbol: TNDM

Analyst Forecast

According to 13 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is $36.36, which is an increase of 79.64% from the latest price.

Price Target

$36.36

(79.64% upside)

Analyst Consensus: Buy